Achilles Therapeutics plc

ACHLNASDAQ Global Select·USD·Closed

ACHLNASDAQ·USD·Closed

$1.48

+0.68%

$1.48

+$0.01 (0.68%)

52W Range

97thpctl

Volume

0.94×avg

Mkt Cap

60.83MUSD

P/E

-0.8TTM

Div Yield

–ann

Healthcare · Biotechnology

52W Range

97thpctl

Volume

0.94×avg

Market Cap

60.83MUSD

P/E Ratio

-0.8TTM

Div Yield

-ann

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC-50.8%

Financially safe

Stretched

Debt / equity0.03×

Interest coverage0.0×

Current ratio8.57×

Continue with finqOS

Unlock the full picture

SEC filings, earnings transcripts, insider trades, institutional ownership, 175+ screening metrics, and an infinite research canvas.

14-day free trial · No credit card required